Alere reports net revenue of $716.

, a global leader in enabling people to take charge of their wellness in the home through the merger of speedy diagnostics and health info solutions, today announced its financial outcomes for the one fourth ended March 31, 2014. Ron Zwanziger, Chairman, Chief Executive Officer and President of Alere said, Despite a difficult quarter from a revenue perspective, related to poor U principally.S. Influenza sales and a larger-than-expected decrease in U.S. Health care utilization which impacted our U.S. Infectious disease revenue, we are pleased to have delivered altered earnings per diluted share more than our prior year's results. Financial outcomes for the first one fourth of 2014: Net income of $716.6 million for the first quarter of 2014, in comparison to $739.2 million for the 1st quarter of 2013.0 million for the 1st quarter of 2014, in comparison to $739.9 million for the first quarter of 2013.For sufferers undergoing aneurysm restoration, the median time from randomization to medical procedures was 44 days in the endovascular-repair group and 35 days in the open-repair group. Of the 12 patients in the endovascular-fix group who didn’t undergo aneurysm repair, 7 died within six months after randomization , 3 became ineligible physically, 1 declined surgery, and 1 became anatomically unsuitable due to a noticeable change in the shape of the aorta. Of the 24 patients in the open-fix group who didn’t undergo aneurysm repair, 7 died within six months after randomization , 7 became physically ineligible, 8 declined surgery , and 2 experienced an unknown reason . Operative Mortality At 30 days after surgery, the numbers of patients who had died had been 11 of 614 sufferers in the endovascular-repair group and 26 of 602 individuals in the open-repair group .